Evaluation of Racial and Ethnic Disparities in the Management of Febrile Infants in Pediatric Emergency Departments
Sunday, April 24, 2022
11:00 AM – 11:15 AM US MT
Location: Convention Center: 708/710/712
CE: Enduring CME: 0.25
Publication Number: 2255.5
Prashant Mahajan, University of Michigan Medical School, Ann Arbor, MI, United States; Tiffani J. Johnson, University of California Davis, Sacramento, CA, United States; Russell K. Banks, University of Utah, Farmington, UT, United States; John M. VanBuren, University of Utah, Salt Lake City, UT, United States; Octavio Ramilo, Nationwide Children's Hospital, Columbus, OH, United States; Nathan Kuppermann, University of California, Davis, School of Medicine, Sacramento, CA, United States; the Febrile Infant Working Group of PECARN (HHS and HRSA), University of Michigan Medical School, Ann Arbor, MI, United States
Presenting Author(s)
Prashant Mahajan, MD MPH MBA
Professor of Pediatrics and Emergency Medicine University of Michigan Medical School Ann Arbor, Michigan, United States
Participants should be aware of the following financial/non-financial relationships:
Prashant Mahajan, MD MPH MBA: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Tiffani J. Johnson, MD, MSC: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Russell K. Banks, Masters of Science - Statistics: I do not have any relevant financial / non-financial relationships with any proprietary interests.
John M. VanBuren, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Octavio Ramilo, MD: ● Adagio (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Lilly (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Merck (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Advisory Committee). ● Pfizer (Currently Ongoing) (Products/Services: Consultant, Advisory Committee). ● Sanofi (Currently Ongoing) (Products/Services: Advisory Committee).
Nathan Kuppermann, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
the Febrile Infant Working Group of PECARN (HHS and HRSA), n/a: I do not have any relevant financial / non-financial relationships with any proprietary interests.